Source: iQoncept / Shutterstock
Eledon Pharma (NASDAQ:ELDN) has just released its fourth-quarter 2023 earnings report.
- Eledon Pharma exceeded expectations by reporting earnings per share of -32 cents, surpassing the analyst consensus of -39 cents.
- However, the company did not disclose any revenue figures for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/eldn-stock-earnings-eledon-pharma-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
